{"pageContent": "Introduction: Focal therapy for localized prostate cancer has the potential for oncological control without the side effects of radical therapies. However, there is currently no validated method for monitoring treatment success. We assessed the diagnostic performance of prostate-specific antigen (PSA) parameters and MRI compared to histological outcomes following focal therapy.", "metaData": {"source": "Prostate changes related to therapy: with special reference to hormone therapy\nhttps://pubmed.ncbi.nlm.nih.gov/25325826/"}}